This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 14 Mar 2022  |  North America  |  Market Outlook

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00
  2. 08 Mar 2022  |  North America  |  Market Outlook

    Global Pharmaceuticals Outlook, 2022

    The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

    Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

    $4,950.00
  3. 15 Dec 2014  |  North America  |  Market Outlook

    Next-generation Healthcare - Global Advanced Medical Technologies 2014

    Disruptions and Transformations are Shaping the Future of Healthcare Delivery

    This study analyzes trends impacting the future of healthcare delivery and market participants. Market solutions are transitioning from models suited to older citizens for use type service models toward business models built around value and quality of service. Companies with solutions around specific procedures or treatments could see attrition as...

    $3,950.00
  4. 03 Jul 2014  |  Asia Pacific  |  Market Outlook

    2014 Asia-Pacific Medical Devices Outlook

    Changing Demographics and Landscape Set Stage for the Future

    Medical devices plays a key role in a vibrant healthcare industry. An increasing aging population with increasing communicable and non-communicale diseases and most governments providing subisidized healthcare translate the need for cost-effective medical devices. Governments need to meet these expectations by policy librealization and revamping re...

    $3,950.00
  5. 21 Mar 2014  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Healthcare Outlook - 2014

    Changing Landscape Impacting Lives

    The study presents an outlook of the healthcare market in the Asia-Pacific. Good healthcare service can impact social issues, economics, and even the politics of a country. Governments need to meet these expectations, but rising costs in population and demographic shifts are causing them to falter. Disparity in care levels is also a concern, especi...

    $4,950.00